Northwest Life Science Specialties Northwest Life Science Specialties (NWLSS) is a company offering assay kits and antibodies for detecting and quantifying various parameters commonly associated with oxidative stress. | Equillium Equillium is a biotechnology company developing products for autoimmune and inflammatory disorders. | STRI STRI (Stem Cell Treatment & Research Institute) is a company developing elicited pluripotent stem cells. | Grace Science Grace Science is a company researching and developing therapeutics to treat NGLY1 deficiency. | ||
Founding Date | Founding Date 2003 | Founding Date 2017 | Founding Date 1989 | Founding Date 2017 | Founding Date 2010 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Vancouver, US HQ | Locations San Diego, US HQ San Francisco, US | Locations KR HQ | Locations Menlo Park, US HQ | Locations Cambridge, US HQ Buenos Aires, AR Sydney, AU São Paulo, BR Toronto, CA Santiago, CL Beijing, CN see more |
Employees | Employees 2 | Employees 1656% decrease | Employees 11 | Employees 16 | Employees 10,60015% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 48.7 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 23.8 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $36.1m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $3.8b (FY, 2024) |
Net income | Net income N/A | Net income ($13.3m) (FY, 2023) | Net income N/A | Net income N/A | Net income ($644.8m) (FY, 2024) |
Equillium is a biotechnology company developing products for autoimmune and inflammatory disorders.
View companySTRI (Stem Cell Treatment & Research Institute) is a company developing elicited pluripotent stem cells.
View companyGrace Science is a company researching and developing therapeutics to treat NGLY1 deficiency.
View companyBeiGene is a biotechnology company that discovers and develops oncology treatments.
View company